Evidence map›Paper›PMID 29581829›Full record

ArticleOncotarget2018

Cystatin A suppresses tumor cell growth through inhibiting epithelial to mesenchymal transition in human lung cancer.

Yunxia Ma, Yuan Chen, Yong Li, Katja Grün, Alexander Berndt, Zhongwei Zhou, Iver Petersen

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Heliyon · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance.International journal of molecular sciences · 2019
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Yunxia MaInstitute of Pathology, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.
Yuan ChenInstitute of Pathology, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.
Yong LiInstitute of Pathology, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.
Katja GrünDepartment of Internal Medicine I, University Hospital Jena, Jena, Germany.
Alexander BerndtInstitute of Pathology, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.
Zhongwei ZhouLeibniz Institute for Age Research, Fritz Lipmann Institute, Jena, Germany.
Iver PetersenCurrent/Present address: Institute of Pathology, SRH Wald-Klinikum Gera, Gera, Germany.
Friedrich Schiller University Jena · DEJena University Hospital · DELeibniz Institute on Aging - Fritz Lipmann Institute (FLI) · DESRH Wald-Klinikum Gera · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystatin A (

Indexed as

cystatin ADNA methylationepithelial to mesenchymal transitionlung cancertumor suppressor

Identifiers

PMID29581829
PMCPMC5865655
OpenAlexW2778860728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.